Kojia Pharmaceutical Holdings Limited announced an updated scope of the Audit Committee, aiming to strengthen the company's financial oversight and risk management. This scope details the composition, responsibilities, and operations of the Audit Committee to ensure the integrity of the company's financial reports and the effectiveness of internal controls.According to the new scope, the Audit Committee consists of at least three non-executive Directors, with independent non-executive Directors constituting the majority. The committee is primarily responsible for overseeing the external audit process, reviewing the company's financial reports, monitoring the internal Control System, and assessing environmental, social, and governance (ESG) related risks. Additionally, the committee meets at least twice a year and has the authority to...Show More

Kojia Pharmaceutical Holdings Limited announced an updated scope of the Audit Committee, aiming to strengthen the company's financial oversight and risk management. This scope details the composition, responsibilities, and operations of the Audit Committee to ensure the integrity of the company's financial reports and the effectiveness of internal controls.According to the new scope, the Audit Committee consists of at least three non-executive Directors, with independent non-executive Directors constituting the majority. The committee is primarily responsible for overseeing the external audit process, reviewing the company's financial reports, monitoring the internal Control System, and assessing environmental, social, and governance (ESG) related risks. Additionally, the committee meets at least twice a year and has the authority to independently contact senior management and seek external professional advice.This update reflects Kojia Pharmaceutical's commitment to enhancing corporate governance, contributing to increased investor confidence. By clarifying the responsibilities and powers of the Audit Committee, the company aims to ensure the accuracy of financial reporting, the effectiveness of risk management, and proper oversight of ESG-related matters, thus promoting the company's long-term sustainable development.